<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00821678</url>
  </required_header>
  <id_info>
    <org_study_id>MHI 08-098</org_study_id>
    <nct_id>NCT00821678</nct_id>
  </id_info>
  <brief_title>Telemedicine Outreach for Post Traumatic Stress in CBOCs</brief_title>
  <acronym>TOP</acronym>
  <official_title>Telemedicine Outreach for Post Traumatic Stress in CBOCs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is improved outcomes for veterans with Post Traumatic Stress
      Disorder (PTSD) treated in small VA Community Based Outpatient Clinics (CBOCs). Although
      psychotherapy and pharmacotherapy treatments for PTSD have been proven to be efficacious in
      controlled trials, geographic barriers often prevent veterans from accessing these
      evidence-based treatments. Telemedicine technologies will be used to overcome geographic
      barriers to care. Specifically, we will evaluate the Telemedicine Outreach for PTSD (TOP)
      intervention which is based on the principals of the Chronic Care Model and Disease
      Management, and builds on the evidence base of quality improvement for depression in primary
      care settings. The TOP intervention will employ an off-site PTSD care team
      (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will
      use telemedicine technologies (telephone, interactive video and electronically shared medical
      records) to treat CBOC patients with a newly emerging or chronic PTSD. We hypothesize that
      study participants randomized to the TOP intervention will receive higher quality of care and
      experience better outcomes compared to study participants randomized to treatment as usual.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 400 Veterans with PTSD will be recruited from nine CBOCs in VISN 16 and 22.
      Veterans screening positive for PTSD and those already in active treatment will be recruited.
      Patients actively engaged in specialty PTSD treatment at the parent VAMC will be excluded.
      Patients will be the unit of randomization. A dedicated nurse telephone care manager will
      educate/activate patients, identify treatment preferences, overcome treatment barriers,
      monitor symptoms, side-effects and adherence, identify psychiatric comorbidities, and
      encourage patient self-management. Tele-pharmacists will provide medication management by
      phone. Tele-psychologists will provide Cognitive Processing Therapy (without exposure) via
      interactive video. Tele-psychiatrists will supervise the off-site care team as well as
      conduct consultations and provide medication management via interactive video. Telephone
      interviews will be administered at baseline, six and twelve months by blinded research
      assistants. Process of care measures will include: 1) whether the veteran received a
      documented treatment concordant with VA/DoD PTSD Treatment Guidelines, 2) self-reported
      adherence to treatment, and 3) satisfaction with care as measured by Experience of Care and
      Health Outcomes (ECHO) Survey. Clinical outcomes will include: 1) PTSD severity as measured
      by the Posttraumatic Diagnostic Scale (PDS), 2) depression severity as measured by the PHQ9,
      3) quantity and frequency of alcohol consumption, 4) health status as measured by the SF12V
      and 5) quality of life as measured by the Quality of Well-Being (QWB) scale. Activity based
      costing methods will be used to measure intervention cost data.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in PTSD Symptom Severity (PDS)</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>range - 0-51 (higher score represents greater severity)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Continuous Measure of Depression Symptom Severity (SCL-20)</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>range - 0-4 (higher score represents greater severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Continuous Measure of Alcohol Use (Audit Score)</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>range - 0-12 (higher score represents greater severity)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Continuous Measure of Health Status (SF12V PCS)</measure>
    <time_frame>6 months</time_frame>
    <description>range - 0-100 (higher score represents greater physical health status)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Continuous Measure of Quality of Life (QWB)</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>range - 0-1 (higher score represents greater wellbeing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Care (ECHO)</measure>
    <time_frame>6 months</time_frame>
    <description>Using any number from 0 to 10, where 0 is the worst care possible and 10 is the best care possible, what number would you use to rate all the care you received for personal or emotional problems in the last 6 months?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Adherence, Defined as Taking Medication &lt;80% of Days</measure>
    <time_frame>6 months</time_frame>
    <description>0 - taking medication &lt;80% of days; 1 - taking medications &gt;=80%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Received at Least 8 Sessions of Exposure Based Therapy</measure>
    <time_frame>12 months</time_frame>
    <description>0 - received &lt;8 sessions of exposure based therapy; 1 - received &gt;=8 sessions of exposure based therapy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">265</enrollment>
  <condition>Posttraumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>Arm 1 Telemedicine Outreach for PTSD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Telemedicine-Based Collaborative Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2 Treatment as usual</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual Care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telemedicine Outreach for PTSD</intervention_name>
    <description>The intervention involves an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and uses telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager educates/activates patients, identifies preferences, overcomes treatment barriers, monitors symptoms, side-effects and adherence, identifies psychiatric comorbidities, and encourages patient self-management. Tele-pharmacists provide medication management by phone. Tele-psychologists provide Cognitive Processing Therapy via interactive video. Tele-psychiatrists supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
    <arm_group_label>Arm 1 Telemedicine Outreach for PTSD</arm_group_label>
    <other_name>Telemedicine-Based Collaborative Care</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnostic Criteria for PTSD (CAPS),

          -  veterans,

          -  treated in CBOC

        Exclusion Criteria:

          -  schizophrenia,

          -  bipolar disorder,

          -  current substance dependence,

          -  current specialty PTSD treatment at VA Medical Center,

          -  no access to telephone,

          -  hearing or speech impediment,

          -  terminal illness,

          -  non-capacity to consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John C. Fortney, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Arkansas Veterans Healthcare System (North Little Rock)</name>
      <address>
        <city>North Little Rock</city>
        <state>Arkansas</state>
        <zip>72114-1706</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Loma Linda</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92357</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Overton Brooks VA Medical Center, Shreveport, LA</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Fortney JC, Pyne JM, Kimbrell TA, Hudson TJ, Robinson DE, Schneider R, Moore WM, Custer PJ, Grubbs KM, Schnurr PP. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. Erratum in: JAMA Psychiatry. 2015 Jan;72(1):96.</citation>
    <PMID>25409287</PMID>
  </results_reference>
  <results_reference>
    <citation>Grubbs KM, Fortney JC, Pyne JM, Hudson T, Moore WM, Custer P, Schneider R, Schnurr PP. Predictors of Initiation and Engagement of Cognitive Processing Therapy Among Veterans With PTSD Enrolled in Collaborative Care. J Trauma Stress. 2015 Dec;28(6):580-4. doi: 10.1002/jts.22049.</citation>
    <PMID>26625355</PMID>
  </results_reference>
  <results_reference>
    <citation>Grubbs KM, Fortney JC, Kimbrell T, Pyne JM, Hudson T, Robinson D, Moore WM, Custer P, Schneider R, Schnurr PP. Usual Care for Rural Veterans With Posttraumatic Stress Disorder. J Rural Health. 2017 Jun;33(3):290-296. doi: 10.1111/jrh.12230. Epub 2017 Jan 23.</citation>
    <PMID>28112433</PMID>
  </results_reference>
  <results_reference>
    <citation>Painter JT, Fortney JC, Austen MA, Pyne JM. Cost-Effectiveness of Telemedicine-Based Collaborative Care for Posttraumatic Stress Disorder. Psychiatr Serv. 2017 Nov 1;68(11):1157-1163. doi: 10.1176/appi.ps.201600485. Epub 2017 Jul 3.</citation>
    <PMID>28669290</PMID>
  </results_reference>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>January 9, 2009</study_first_submitted>
  <study_first_submitted_qc>January 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2009</study_first_posted>
  <results_first_submitted>February 19, 2015</results_first_submitted>
  <results_first_submitted_qc>April 6, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 23, 2015</results_first_posted>
  <last_update_submitted>December 14, 2018</last_update_submitted>
  <last_update_submitted_qc>December 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>telemedicine</keyword>
  <keyword>rural</keyword>
  <keyword>veterans</keyword>
  <keyword>care management</keyword>
  <keyword>psychotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm 1 Telemedicine Outreach for PTSD</title>
          <description>Telemedicine-Based Collaborative Care
Telemedicine Outreach for PTSD: The Telemedicine Outreach for PTSD (TOP) intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager will educate/activate patients, identify treatment preferences, overcome treatment barriers, monitor symptoms, side-effects and adherence, identify psychiatric comorbidities, and encourage patient self-management. Tele-pharmacists will provide medication management by phone. Tele-psychologists will provide Cognitive Processing Therapy (without exposure) via interactive video. Tele-psychiatrists will supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
        </group>
        <group group_id="P2">
          <title>Arm 2 Treatment as Usual</title>
          <description>Treatment as usual</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="133"/>
                <participants group_id="P2" count="132"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="112"/>
                <participants group_id="P2" count="118"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1 Telemedicine Outreach for PTSD</title>
          <description>Telemedicine-Based Collaborative Care
Telemedicine Outreach for PTSD: The Telemedicine Outreach for PTSD (TOP) intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager will educate/activate patients, identify treatment preferences, overcome treatment barriers, monitor symptoms, side-effects and adherence, identify psychiatric comorbidities, and encourage patient self-management. Tele-pharmacists will provide medication management by phone. Tele-psychologists will provide Cognitive Processing Therapy (without exposure) via interactive video. Tele-psychiatrists will supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
        </group>
        <group group_id="B2">
          <title>Arm 2 Treatment as Usual</title>
          <description>Treatment as usual</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="133"/>
            <count group_id="B2" value="132"/>
            <count group_id="B3" value="265"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.9" spread="14.0"/>
                    <measurement group_id="B2" value="52.5" spread="13.6"/>
                    <measurement group_id="B3" value="52.2" spread="13.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="118"/>
                    <measurement group_id="B2" value="120"/>
                    <measurement group_id="B3" value="238"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Caucasian Non-Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="92"/>
                    <measurement group_id="B3" value="169"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caucasian Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Race/Ethnicity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in PTSD Symptom Severity (PDS)</title>
        <description>range - 0-51 (higher score represents greater severity)</description>
        <time_frame>Baseline, 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Telemedicine Outreach for PTSD</title>
            <description>Telemedicine-Based Collaborative Care
Telemedicine Outreach for PTSD: The Telemedicine Outreach for PTSD (TOP) intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager will educate/activate patients, identify treatment preferences, overcome treatment barriers, monitor symptoms, side-effects and adherence, identify psychiatric comorbidities, and encourage patient self-management. Tele-pharmacists will provide medication management by phone. Tele-psychologists will provide Cognitive Processing Therapy (without exposure) via interactive video. Tele-psychiatrists will supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Treatment as Usual</title>
            <description>Treatment as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Change in PTSD Symptom Severity (PDS)</title>
          <description>range - 0-51 (higher score represents greater severity)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.31" spread="10.91"/>
                    <measurement group_id="O2" value="-1.07" spread="7.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Slope</param_type>
            <param_value>-3.81</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.19</ci_lower_limit>
            <ci_upper_limit>-1.43</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Continuous Measure of Depression Symptom Severity (SCL-20)</title>
        <description>range - 0-4 (higher score represents greater severity</description>
        <time_frame>Baseline, 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Telemedicine Outreach for PTSD</title>
            <description>Telemedicine-Based Collaborative Care
Telemedicine Outreach for PTSD: The Telemedicine Outreach for PTSD (TOP) intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager will educate/activate patients, identify treatment preferences, overcome treatment barriers, monitor symptoms, side-effects and adherence, identify psychiatric comorbidities, and encourage patient self-management. Tele-pharmacists will provide medication management by phone. Tele-psychologists will provide Cognitive Processing Therapy (without exposure) via interactive video. Tele-psychiatrists will supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Treatment as Usual</title>
            <description>Treatment as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Continuous Measure of Depression Symptom Severity (SCL-20)</title>
          <description>range - 0-4 (higher score represents greater severity</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.43" spread="0.62"/>
                    <measurement group_id="O2" value="-0.16" spread="0.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Slope</param_type>
            <param_value>-0.25</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.4</ci_lower_limit>
            <ci_upper_limit>-0.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Continuous Measure of Alcohol Use (Audit Score)</title>
        <description>range - 0-12 (higher score represents greater severity)</description>
        <time_frame>Baseline, 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Telemedicine Outreach for PTSD</title>
            <description>Telemedicine-Based Collaborative Care
Telemedicine Outreach for PTSD: The Telemedicine Outreach for PTSD (TOP) intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager will educate/activate patients, identify treatment preferences, overcome treatment barriers, monitor symptoms, side-effects and adherence, identify psychiatric comorbidities, and encourage patient self-management. Tele-pharmacists will provide medication management by phone. Tele-psychologists will provide Cognitive Processing Therapy (without exposure) via interactive video. Tele-psychiatrists will supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Treatment as Usual</title>
            <description>Treatment as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Continuous Measure of Alcohol Use (Audit Score)</title>
          <description>range - 0-12 (higher score represents greater severity)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.36" spread="2.19"/>
                    <measurement group_id="O2" value="-0.17" spread="1.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.48</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.18</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.33</ci_lower_limit>
            <ci_upper_limit>0.70</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Continuous Measure of Health Status (SF12V PCS)</title>
        <description>range - 0-100 (higher score represents greater physical health status)</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Telemedicine Outreach for PTSD</title>
            <description>Telemedicine-Based Collaborative Care
Telemedicine Outreach for PTSD: The Telemedicine Outreach for PTSD (TOP) intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager will educate/activate patients, identify treatment preferences, overcome treatment barriers, monitor symptoms, side-effects and adherence, identify psychiatric comorbidities, and encourage patient self-management. Tele-pharmacists will provide medication management by phone. Tele-psychologists will provide Cognitive Processing Therapy (without exposure) via interactive video. Tele-psychiatrists will supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Treatment as Usual</title>
            <description>Treatment as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Continuous Measure of Health Status (SF12V PCS)</title>
          <description>range - 0-100 (higher score represents greater physical health status)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.77" spread="7.50"/>
                    <measurement group_id="O2" value="-1.45" spread="9.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Slope</param_type>
            <param_value>2.67</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.45</ci_lower_limit>
            <ci_upper_limit>4.91</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Continuous Measure of Quality of Life (QWB)</title>
        <description>range - 0-1 (higher score represents greater wellbeing)</description>
        <time_frame>Baseline, 6 months</time_frame>
        <population>Full sample</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Telemedicine Outreach for PTSD</title>
            <description>Telemedicine-Based Collaborative Care
Telemedicine Outreach for PTSD: The intervention involves an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and uses telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager educates/activates patients, identifies preferences, overcomes treatment barriers, monitors symptoms, side-effects and adherence, identifies psychiatric comorbidities, and encourages patient self-management. Tele-pharmacists provide medication management by phone. Tele-psychologists provide Cognitive Processing Therapy via interactive video. Tele-psychiatrists supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Treatment as Usual</title>
            <description>Usual Care</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Continuous Measure of Quality of Life (QWB)</title>
          <description>range - 0-1 (higher score represents greater wellbeing)</description>
          <population>Full sample</population>
          <units>Units on a Scale from 0-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00407" spread="0.1086"/>
                    <measurement group_id="O2" value="-0.00800" spread="0.1019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction With Care (ECHO)</title>
        <description>Using any number from 0 to 10, where 0 is the worst care possible and 10 is the best care possible, what number would you use to rate all the care you received for personal or emotional problems in the last 6 months?</description>
        <time_frame>6 months</time_frame>
        <population>Full sample. Data missing for 1 Arm 1 subject and 3 Arm 2 subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Telemedicine Outreach for PTSD</title>
            <description>Telemedicine-Based Collaborative Care
Telemedicine Outreach for PTSD: The Telemedicine Outreach for PTSD (TOP) intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager will educate/activate patients, identify treatment preferences, overcome treatment barriers, monitor symptoms, side-effects and adherence, identify psychiatric comorbidities, and encourage patient self-management. Tele-pharmacists will provide medication management by phone. Tele-psychologists will provide Cognitive Processing Therapy (without exposure) via interactive video. Tele-psychiatrists will supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Treatment as Usual</title>
            <description>Treatment as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction With Care (ECHO)</title>
          <description>Using any number from 0 to 10, where 0 is the worst care possible and 10 is the best care possible, what number would you use to rate all the care you received for personal or emotional problems in the last 6 months?</description>
          <population>Full sample. Data missing for 1 Arm 1 subject and 3 Arm 2 subjects</population>
          <units>0-10 self reported rating</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="111"/>
                <count group_id="O2" value="115"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.83423" spread="1.17964"/>
                    <measurement group_id="O2" value="7.7043" spread="2.2671"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Medication Adherence, Defined as Taking Medication &lt;80% of Days</title>
        <description>0 - taking medication &lt;80% of days; 1 - taking medications &gt;=80%</description>
        <time_frame>6 months</time_frame>
        <population>Sample only for 205 patients prescribed medications.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Telemedicine Outreach for PTSD</title>
            <description>Telemedicine-Based Collaborative Care
Telemedicine Outreach for PTSD: The Telemedicine Outreach for PTSD (TOP) intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager will educate/activate patients, identify treatment preferences, overcome treatment barriers, monitor symptoms, side-effects and adherence, identify psychiatric comorbidities, and encourage patient self-management. Tele-pharmacists will provide medication management by phone. Tele-psychologists will provide Cognitive Processing Therapy (without exposure) via interactive video. Tele-psychiatrists will supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Treatment as Usual</title>
            <description>Treatment as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Medication Adherence, Defined as Taking Medication &lt;80% of Days</title>
          <description>0 - taking medication &lt;80% of days; 1 - taking medications &gt;=80%</description>
          <population>Sample only for 205 patients prescribed medications.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="104"/>
                <count group_id="O2" value="101"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.65</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Odds Ratio, log</param_type>
            <param_value>0.86</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.46</ci_lower_limit>
            <ci_upper_limit>1.62</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Received at Least 8 Sessions of Exposure Based Therapy</title>
        <description>0 - received &lt;8 sessions of exposure based therapy; 1 - received &gt;=8 sessions of exposure based therapy</description>
        <time_frame>12 months</time_frame>
        <population>Full Baseline Sample</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Telemedicine Outreach for PTSD</title>
            <description>Telemedicine-Based Collaborative Care
Telemedicine Outreach for PTSD: The Telemedicine Outreach for PTSD (TOP) intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager will educate/activate patients, identify treatment preferences, overcome treatment barriers, monitor symptoms, side-effects and adherence, identify psychiatric comorbidities, and encourage patient self-management. Tele-pharmacists will provide medication management by phone. Tele-psychologists will provide Cognitive Processing Therapy (without exposure) via interactive video. Tele-psychiatrists will supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Treatment as Usual</title>
            <description>Treatment as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Received at Least 8 Sessions of Exposure Based Therapy</title>
          <description>0 - received &lt;8 sessions of exposure based therapy; 1 - received &gt;=8 sessions of exposure based therapy</description>
          <population>Full Baseline Sample</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
                <count group_id="O2" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>7.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>3.2</ci_lower_limit>
            <ci_upper_limit>19.6</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>Death (Not Study Related). Death was the only adverse event monitored.</desc>
      <group_list>
        <group group_id="E1">
          <title>Arm 1 Telemedicine Outreach for PTSD</title>
          <description>Telemedicine-Based Collaborative Care
Telemedicine Outreach for PTSD: The Telemedicine Outreach for PTSD (TOP) intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records). A dedicated nurse telephone care manager will educate/activate patients, identify treatment preferences, overcome treatment barriers, monitor symptoms, side-effects and adherence, identify psychiatric comorbidities, and encourage patient self-management. Tele-pharmacists will provide medication management by phone. Tele-psychologists will provide Cognitive Processing Therapy (without exposure) via interactive video. Tele-psychiatrists will supervise the off-site care team as well as conduct consultations and provide medication management via interactive video.</description>
        </group>
        <group group_id="E2">
          <title>Arm 2 Treatment as Usual</title>
          <description>Treatment as usual</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>Chart Review</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="133"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="132"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death (Not Study Related)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="133"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="132"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="133"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="132"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>High enrollment refusal rates may limit external validity.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>John Fortney</name_or_title>
      <organization>VA HSR&amp;D</organization>
      <phone>206.764.2821</phone>
      <email>john.fortney@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

